The Diagnosis of Pancreatic Cancer

Cancer Journal

Volumn 7, Issue 4, 2001, Pages 287-297

  Brand, Randall ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Imaging; Pancreatic cancer; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

BLOOD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; PANCREAS TUMOR; REVIEW; RISK FACTOR;

CARCINOEMBRYONIC ANTIGEN; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; ENDOSONOGRAPHY; HUMANS; PANCREATIC NEOPLASMS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035409103     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M Cancer Statistics 2001. CA Cancer J Clin 2001;51:15-36.
2. Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma Pancreas 1998;16:396-401.
3. Lillemoe KD, Yeo CJ, Cameron JL Pancreatic cancer: State-of-the-art care CA Cancer J Clin 2000;50:241-268
4. Parks RW, Garden OJ Ensuring early diagnosis in pancreatic cancer. The Practitioner 2000;244:336-343
5. Barkin JS, Goldstein JA. Diagnostic and therapeutic approach to pancreatic cancer Biomed Pharmacother 2000;54:400-409
6. DiMagno EP Pancreatic cancer. Clinical presentation, pitfalls and early clues Ann Oncol 1999;10 (Suppl 4):S140-S142.
7. DiMagno EP, Malagelada JR, Taylor WP et al A prospective comparison of current diagnostic tests in pancreatic cancer N Engl J Med 1977;97 737-742
8. Krech RL, Walsh D Symptoms of pancreatic cancer. J Pain Symptom Mgt 1991;6:360-367
9. Norton ID, Petersen BT, Miller IJ et al. Frequency of a family history of pancreatic malignancy in patients with pancreatic malignancy. Pancreas 1998;17:451.
10. Brand RE, Lynch HT Hereditary pancreatic adenocarcinoma. A clinical perspective In: Whitcomb DC, Cohn JA, Ulrich CD, eds The Medical Clinics of North America: Inherited Diseases of the Pancreas. Philadelphia PA. W.B. Saunders Co., 2000 665-675.
11. Falk T, Pickle LW, Fontham ET et al Life-style risk factors for pancreatic cancer in Louisiana: A case-control study. Am J Epidemiol 1988;18 324-336
12. Fernandez E LaVecchia C, D'Avanzo B et al Family history and the risk of liver, gallbladder, and pancreatic cancer Cancer Epidemiol Biomarkers Prev 1994;3:209-212
13. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer Surg Oncol Clin N Am 1998;7:67-91.
14. Schenk M, Schwartz AG, O'Neal E et al. Familial risk of pancreatic cancer J Natl Cancer Inst 2001;93 640-644.
15. Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis In Whitcomb DC, Cohn JA, Ulrich CD, eds. The Medical Clinics of North America: Inherited Diseases of the Pancreas Philadelphia, PA. W.B. Saunders Co., 2000: 565-572.
16. Ishiguchi T, Maruyama K, Fukatsu H, Ishigaki T. Radiologic diagnosis of pancreatic carcinoma. Semin Surg Oncol 1998;15:23-32.
17. Friedman AC, Krudy AG Jr, Shawker TH Pancreatic neoplasms. In. Friedman AC, ed. Radiology of the Liver, Biliary Tract, Pancreas and Spleen Baltimore Williams&Wilkins, 1987 749-886
18. Ormson MJ, Carboneau JW, Stephens DH Sonography in patients with a possible pancreatic mass shown on CT. Am J Roentgenol 1987;148:551-555
19. Campbell JP, Wilson SR. Pancreatic neoplasms: how useful is evaluation with US? Radiology 1988;167 341-344.
20. Del Maschio A, Vanzulli A, Sironi S et al Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy. Radiology 1991;178:95-99
21. Warshaw AL, Fernández del Castillo C Pancreatic carcinoma N Engl J Med 1992;326:455-465.
22. Forsmark CE, Albert CA, Lambiase L et al. Diagnostic tests for pancreatic cancer [abstract]. Gastrointest Endosc 1993;39 314.
23. Kallimanis G, Axiotis E, Paptoniou P EUS, ERCP, US, CT in the diagnosis of pancreatic cancer [abstract] Endoscopy 1992;24: 656
24. Yasuda K, Makai H, Fujimoto S et al. The diagnosis of pancreatic cancer by endoscopie ultrasonography. Gastrointest Endosc 1988; 34:1-8
25. Rösch T, Lorenz R, Braig C et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991;37:347-352
26. Pollock D, Taylor KJW Ultrasound scanning in patients with clinical suspicion of pancreatic cancer a retrospective study. Cancer 1981;47 1662-1665
27. Karlson BM, Ekbom A, Lindgren PG et al. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology 1999;213 107-111
28. Nghiem HV, Freeny PC Radiologic staging of pancreatic adenocarcinoma. Radiol Clin N Am 1994;32:71-79
29. Dupuy DE, Costello P, Ecker CP Spiral CT of the pancreas Radiology 1992;83:815-818.
30. Ferrucci JT, Biliopancreatic malignancy current diagnostic possibilities An overview. Ann Oncol 1999;10 S143-S144
31. Freeny PC, Marks WM, Rayn JA, Traverse LV. Pancreatic ductal adenocarcinoma Diagnosis and staging with dynamic CT Radiology 1988;166:125-133
32. Freeny PC. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma Radiol Clin N Am 1989;27:121-128.
33. Ward EM, Stephens DH, Sheedy PH Computed tomographic characteristics of pancreatic carcinoma: an analysis of 100 cases. Radiographies 1983;3 547-565
34. Wittenberg J, Simeone JE, Ferrucci JT Jr et al. Non-focal enlargement in pancreatic carcinoma Radiology 1982;141:131-135
35. Freeny PC, Marks WM, Ryan JA, Traverso LW. Pancreatic ductal adenocarcinoma diagnosis and staging with dynamic CT Radiology 1988;166(1 pt 1):125-133.
36. Shimamoto K, Ishiguchi T, Sakuma S. CT evaluation of pancreatic cancer. Analysis of resected tumors Eur J Radiol 1987;7:37-41.
37. Sugiyama S, Asada M, Fujita R, Suagat F Endoscopic ultrasonography for the diagnosis of pancreatic carcinoma [abstract]. Endoscopy 1988;20:94
38. Hessel SJ, Siegelman SS, McNeil BJ et al Pancreatic adenocarcinoma: diagnosis and staging with CT and complementary imaging. Radiology 1988;143:129-133.
39. Bluemke DA, Cameron JL, Hruban RH et al Potentially resectable pancreatic adenocarcinoma spiral CT assessment with surgical and pathologic correlation Radiology 1995;197:381-385.
40. Aliperti G Complications related to diagnostic and therapeutic endoscopie retrograde cholangiopancreatography. Gastrointest Endosc Clin North Am 1996;6:379-407.
41. Freeman ML, Nelson DB, Sherman S et al. Complications of endoscopie biliary sphincterotomy. N Engl J Med 1996;335 909-918.
42. Kozarek R. Endoscopy in the management of malignant obstructive jaundice. Gastrointest Endosc Clin N Am 1996;6:153-176.
43. Kubota Y, Takaoka M, Tain K et al. Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures. Am J Gastroenterol 1992;88:1700-1704
44. Ferrari AP, Lichtenstein DR, Slivka A et al. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endosc 1994;40:140-145.
45. Murr MM, Sarr MG, Oishi AJ, Heerden JA. Pancreatic cancer. CA Cancer J Clin 1994;44:304-318.
46. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma: imaging techniques and tumor markers. Pancreas 1992;7:66-86.
47. Frick MP, O'Leary JF, Walker C Jr, Goodale RL. Accuracy of endoscopic retrograde cholangiopancreatography in differentiating benign and malignant pancreatic disease. Gastrointest Radiol 1982;7:241-244
48. Brentnall TA, Bronner MP, Byrd DR et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131 247-255.
49. Foerster EC, Trommer P, Schneider MU et al Transpapillary miniscopy and mini-biopsy of the pancreatic duct. Endoscopy 1990;22 78-80
50. Tajiri H, Kobayashi M, Niwa H, Furui S Clinical application of an ultra-thin pancreatoscope using a sequential video converter. Gastrointest Endosc 1993;39:371-374
51. Uehara H, Nakaizumi A, Tatsuta M et al. Diagnosis of carcinoma in situ of the pancreas by peroral pancreatscopy and pancreatoscopic cytology. Cancer 1997;79 454-460.
52. Zuiani C, Bendini M, Meduri S et al Magnetic resonance with fat-saturation sequences in studying the upper abdomen: The normal semeiological aspects. Radiol Med Torino 1996;91:405-412
53. Semelka RC, Ascher SM. MR imaging of the pancreas Radiology 1993;188 593-602.
54. Diehl SJ, Lehmann KJ, Gaa J et al. MR Imagining of pancreatic lesions comparison of manganese-DPDP and gadolinium chelate. Invest Radiol 1999;34:589-595
55. Müller MF, Meyenberger C, Bertschinger P et al Pancreatic tumors evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745-751.
56. Vellet AD, Romano W, Bach DB et al. Adenocarcinoma of the pancreatic ducts comparative evaluation with CT and MR imaging at 1.5 T Radiology 1992;183:87-95.
57. Ueno E, Takada Y, Yoshida I et al. Pancreatic diseases evaluation with MR cholangiopancreatography Pancreas 1998;16 418-426.
58. Ferruci JT MRI and MRCP in pancreaticobiliary malignancy Ann Oncol 1999;10 (Suppl 4):S18-S19
59. Adamek HE, Albert J, Breer H et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatopraphy a prospective controlled study Lancet 2000;356:190-193
60. Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma Pancreas 1998;16:396-401.
61. Reinhold C, Bret PM. Current status on MR cholangiopancreatography. Am J Roentgenol 1996;166:1285-1295.
62. Warburg O The Metabolism of Tumors. London Constable, 1930
63. 18F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool Prog Clin Radiol 1987;22:360-371.
64. Kubota K, Matsuzawa T, Fujiwara T et al Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927-1932.
65. Nieweg OE, Kim EE, Wong W et al Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer Cancer 1993;71 3920-3925
66. Strauss LG, Clonus JH, Schlag P et al. Recurrence of colorectal tumors PET evaluation Radiology 1989;270:329-332.
67. Tempero M, Brand R, Holdeman K, Matamoros A. New imaging techniques in colorectal cancer Semin Oncol 1995;22:448-471.
68. Inokuma T, Tamaki N, Torizuka T et al Evaluation of pancreatic tumor with positron emission tomography and F-18-fluorodeoxyglucose: comparison with CT and US Radiology 1995;195 345-352
69. Büchler M, Langhans J, Beger G, Reske SN. Concordantly increased glucose transporter 1 (glut 1) gene expression and FDG-uptake in human pancreatic carcinoma [abstract]. J Nucl Med 1993;34 223P.
70. Stollfuss J, Glatting G, Friess H et al 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation Radiology 1995;195:339-344
71. Bares R, Klever P, Hauptmann S et al F-18-fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79-86.
72. Kato T, Fukatsu H, Ito K et al Fluorodeoxyglucose positron emission tomography in pancreatic cancer an unsolved problem. Eur J Nucl Med 1995;22:32-39
73. 18F-Fluro-2-Deoxy-D-Glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas Cancer 2000;89:2547-2554
74. Yasuda K, Mukai H, Nakajima M. Endoscopic ultrasonography diagnosis of pancreatic cancer Gastrointest Enclose Clin N Am 1995;5:699-712.
75. Furukawa T, Tsukamoto Y, Naitoh Y et al Evaluation of intraductal ultrasonography in the diagnosis of pancreatic cancer. Endoscopy 1993;25:577-581.
76. Furukawa T, Tsukamoto Y, Naitoh Y, Hirooka Y, Hayakawa T. Differential diagnosis between benign and malignant localized stenosis of the mam pancreatic duct by intraductal ultrasound of the pancreas. Am J Gastroenterol 1994;89:2038-2041
77. Forsmark CE. Differential diagnosis of pancreatic tumors. Gastrointest Endosc Clin N Am 1995;5:713-721.
78. Nakaizumi A, Uehara H, Iishi H et al Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer Dig Dis Sci 1995;40:696-700.
79. Yasuda K, Tanaka Y, Fujimoto S et al. Use of endoscopic ultrasonography in small pancreatic cancer Scand J Gastroenterol 1984;19 9-17.
80. Rösch T Diagnosis and staging of pancreatic cancer by EUS: a critical analysis Proceedings of the 10th International Symposium on Endoscopic Ultrasonography. Cleveland, OH, October 25-27; 1995: 153-162
81. Vildmann P, Jacobsen GK, Henriksen FW, Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 1992;38:172-173
82. Chang KJ. Endoscopic ultrasound-guided fine needle aspiration in the diagnosis and staging of pancreatic tumors. Gastrointest Endosc Clin N Am 1995;5 723-734.
83. Gress F, Gottlieb K, Sherman S, Lehman G Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001;134 459-464
84. Brand R, Matamores A Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Digest Dis 1998;16:242-252
85. Abbruzzese J. Molecular diagnosis of pancreatic and biliary cancer: Ready for broad implementation? Cancer J 2000;6:282-284.
86. Barkin JS, Goldstein JA Diagnostic and therapeutic approach to pancreatic cancer. Biomed Pharmacother 2000;54:400-409.
87. Furakawa H, Okada S, Kakizoe T. Early diagnosis of pancreatic cancer. Hepato-Gastroenterology 1999;46 4-7.
88. Mulcahy H, Farthing MJG. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool. Ann Oncol 1999;10 (Suppl 4) S114-S117.
89. Caldas C. Biliopancreatic malignancy. Screening the at risk patient with molecular markers. Ann Oncol 1999;10 (Suppl 4):S153-S156.
90. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85 350-355.
91. Matsumoto S, Harada H, Tanaka J et al Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages. Pancreas 1994; 9:741-747.
92. Almoguerra C, Shibata D, Forrester K et al Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53 549-554
93. Iguchi H, Sugano K, Fukayama N et al. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 1996, 110:221-226
94. Watanabe H, Yamaguchi Y, Ha A et al Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay Pancreas 1998;17:341-347
95. Nakamura Y, Onda M, Uchida E. Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma. Pancreas 1999;18:133-140
96. Berthelemy P, Boisson M, Escorron S et al. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995;123:188-191.
97. Wakabayashi T, Sawabu N, Watanabe H et al. Detection of K-ras point mutation at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer. Am J Gastroenterol 1996;91:1848-1851.
98. Pellegata S, Sessa F, Renault B et al. K-ras and p53 gene mutations m pancreatic cancer ductal and nonductal tumors progress through different genetic lesions Cancer Res 1994;54 1556-1560.
99. Redston MS, Caldas C, Seymour AB et al: p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions Cancer Res 1994;54:3025-3033
100. Rozenblum E, Schutte M, Goggins M. Tumor-suppressor pathways in pancreatic carcinoma. Cancer Res 1997;57:1731-1734
101. Laurent-Puig P, Lubin R, Semhoun-Ducloux S et al. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. Gut 1995;36:455-458.
102. Iwao T, Hanada K, Tsuchida A et al. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations Cancer 1998;82 1487-1494.
103. Lundin J, Roberts PJ, Kuusela P, Haglund C. Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9. Anticancer Res 1995;15:2181-2186.
104. Permert J, Larsson J, Westermark GT et al Islet amyloid polypeptide inpatients with pancreatic cancer and diabetes. N Eng J Med 1994;330:313-318.
105. Brand RE, Ding XZ, Young CM, Adrian TE. The specificity of amylin for the diagnosis of pancreatic cancer [abstract]. Gastroenterology 2000;118:1482.
106. Spern C, Pasquali C, Quolo P et al. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Cancer 1996;78:237-243
107. Zakian VA. Telomerase: Beginning to understand the end. Science 1997;270:1601-1607.
108. Biessmann H, Mason JM. Genetics and molecular biology of telomeres. Adv Genet 1992;30:185.
109. Kim NW, Piatyszek MA, Prowse KR et al Specific association of human telomerase activity with immortal cells and cancer Science 1994;266:2011.
110. Counter CM, Avilion AA, LeFeuvre CE et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity EMBO J 1992;11:1921-1929
111. Hiyama E, Kodama T, Shinbara K et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors Cancer Res 1997;57:326-331
112. Mizumoto K, Suehara N, Muta T et al. Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma J Gastroenterol 1996;31:894-897.
113. Buchler P, Conejo-Garcia JR, Lehman G et al. Real-Time Quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders. Pancreas, 2001;22:331-340
114. Iwao T, Hiyama E, Yok T et al Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 1997;89:1621-1623
115. Suehara N, Mizumoto K, Tanaka M et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997;3:2479-2483
116. Suehara N, Mizumoto K, Kusumoto M et al Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer Am J Gastroenterol 1998;93:1967-1971
117. Slesak B, Harlozinska-Szmyrka A, Knast W et al Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis: a comparative study with Ca 19-9 Cancer 2000;89:83-88.
118. Zhou W, Sokoll L, Bruzek DJ et al. Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomark Prev 1998;7:109-112.
119. Suresh MR Classification of turn or markers. Anticancer Res 1996;16:2273-2278